bleeding and thrombotic complications in car t-cell therapy for b-cell malignancies
Published 3 years ago • 88 plays • Length 3:25Download video MP4
Download video MP3
Similar videos
-
3:31
the role of lymphodepletion in car t-cell therapy: current knowledge & the need for personalization
-
2:20
the risk of t-cell malignancies associated with car t-cell therapy
-
1:15
car t-cells in hematological malignancies
-
1:09
the promise of car t-cell therapy in hematological malignancies
-
3:06
repeat infusions of cd19 car-t
-
2:48
the novel icaht grading system to predict toxicity following car t-cell therapy
-
1:49
a novel subcutaneous car-t therapy for the treatment of hematological malignancies
-
2:06
an insight into the sequencing of car-t and bispecifics in myeloma
-
0:45
car-t resistance in tp53-mutated b-all: a loss of signalling
-
1:51
regulatory and commercialization challenges with car t-cell therapy
-
1:39
the role of myeloid cells in car-t cell therapy
-
2:33
the effect of lymphodepleting agents on rate and severity of toxicities following car-t infusion
-
3:05
the development of inkt-car t-cells for hematological malignancies
-
2:10
mechanisms of resistance to car t-cells in myeloma & future considerations
-
1:18
the importance of lymphodepletion, an undervalued component of the car-t therapy cycle
-
4:24
investigating production failure and out-of-specification production of car t-cell therapeutics
-
1:10
tackling resistance to car-t therapy across hematological malignancies
-
3:03
the impact of salvage and bridging therapy on car t-cell therapy outcomes in b-all: an itt analysis
-
3:14
using machine learning to identify trajectories of hematotoxicity following car t-cell therapy